CCL2 is a Potent Regulator of Prostate Cancer Cell Migration and Proliferation
Open Access
- 1 July 2006
- Vol. 8 (7), 578-586
- https://doi.org/10.1593/neo.06280
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxisNature Immunology, 2005
- Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functionsBiochemical and Biophysical Research Communications, 2005
- Osteoblasts in prostate cancer metastasis to boneNature Reviews Cancer, 2005
- Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migrationBlood, 2004
- Cancer and the chemokine networkNature Reviews Cancer, 2004
- LY294002 inhibits monocyte chemoattractant protein‐1 expression through a phosphatidylinositol 3‐kinase‐independent mechanismFEBS Letters, 2004
- Progression of mouse mammary tumors: MCP‐1‐TNFα cross‐regulatory pathway and clonal expression of promalignancy and antimalignancy factorsInternational Journal of Cancer, 2003
- Monocyte chemoattractant protein‐1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomasInternational Journal of Cancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.Journal of Clinical Investigation, 1995